Bamco Inc Applied Therapeutics Inc. Transaction History

Bamco Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$13.54 - $22.06 $3.22 Million - $5.25 Million	-237,800 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$16.57 - $28.65 $1.84 Million - $3.17 Million	110,800 Added 87.24%	237,800 $4.46 Million
Q4 2020 Feb 12, 2021	SELL	$15.44 - $24.23 $55,445 - $87,009	-3,591 Reduced 2.75%	127,000 $2.8 Million
Q3 2020 Nov 13, 2020	SELL	$19.43 - $35.36 $2.39 Million - $4.35 Million	-122,900 Reduced 48.48%	130,591 $2.71 Million
Q2 2020 Aug 14, 2020	BUY	$29.41 - $51.23 $4.81 Million - $8.37 Million	163,400 Added 181.37%	253,491 $9.16 Million
Q1 2020 May 15, 2020	BUY	$19.54 - $55.47 $1.76 Million - $5 Million	90,091 New	90,091 $2.95 Million

140

112M

1.68M

1.91M

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $442M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.